BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Börzsei R, Pozsgai G, Bagoly T, Elekes K, Pintér E, Szolcsányi J, Helyes Z. Inhibitory action of endomorphin-1 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Neuroscience 2008;152:82-8. [PMID: 18248905 DOI: 10.1016/j.neuroscience.2007.12.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Martínez-Martínez E, Galván-Hernández CI, Toscano-Márquez B, Gutiérrez-Ospina G. Modulatory role of sensory innervation on hair follicle stem cell progeny during wound healing of the rat skin. PLoS One 2012;7:e36421. [PMID: 22574159 DOI: 10.1371/journal.pone.0036421] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
2 Bodnar RJ. Endogenous opiates and behavior: 2008. Peptides 2009;30:2432-79. [PMID: 19793543 DOI: 10.1016/j.peptides.2009.09.027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
3 Szőke É, Bálint M, Hetényi C, Markovics A, Elekes K, Pozsgai G, Szűts T, Kéri G, Őrfi L, Sándor Z, Szolcsányi J, Pintér E, Helyes Z. Small molecule somatostatin receptor subtype 4 (sst4) agonists are novel anti-inflammatory and analgesic drug candidates. Neuropharmacology 2020;178:108198. [PMID: 32739276 DOI: 10.1016/j.neuropharm.2020.108198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Machelska H, Celik MÖ. Immune cell-mediated opioid analgesia. Immunol Lett 2020;227:48-59. [PMID: 32814155 DOI: 10.1016/j.imlet.2020.08.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Stein C, Machelska H, Sharp BM. Modulation of Peripheral Sensory Neurons by the Immune System: Implications for Pain Therapy. Pharmacol Rev 2011;63:860-81. [DOI: 10.1124/pr.110.003145] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 11.9] [Reference Citation Analysis]
6 Stein C, Küchler S. Targeting inflammation and wound healing by opioids. Trends Pharmacol Sci 2013;34:303-12. [PMID: 23602130 DOI: 10.1016/j.tips.2013.03.006] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 9.8] [Reference Citation Analysis]
7 Russjan E, Andrzejewski K, Sulejczak D, Kleczkowska P, Kaczyńska K. Endomorphin-2- and Neurotensin- Based Chimeric Peptide Attenuates Airway Inflammation in Mouse Model of Nonallergic Asthma. Int J Mol Sci 2019;20:E5935. [PMID: 31779093 DOI: 10.3390/ijms20235935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Fernández-dueñas V, Ciruela F, Gandía J, Sánchez S, Planas E, Poveda R. Histamine H3 receptor activation potentiates peripheral opioid-mediated antinociception: Substance P role in peripheral inflammation in mice. European Journal of Pharmacology 2010;638:72-7. [DOI: 10.1016/j.ejphar.2010.04.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
9 Niu L, Chen T, Wang YY, Li YQ. Neurochemical phenotypes of endomorphin-2-containing neurons in vagal nodose neurons of the adult rat. Neurochem Int. 2009;55:542-551. [PMID: 19463881 DOI: 10.1016/j.neuint.2009.05.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
10 Singh R, Xie W, Williams J, Vince R, More SS. Discovery of Anticancer Clinical Candidate, Tosedostat, As an Analgesic Agent. ACS Chem Neurosci 2019;10:4007-17. [PMID: 31415151 DOI: 10.1021/acschemneuro.9b00230] [Reference Citation Analysis]
11 Cui J, Zhao L, Wang Z, Ma M, Wang Y, Luo K, Wang L, Wei S, Zhang X, Han C, Liu X, Wang R. MEL endomorphins act as potent inflammatory analgesics with the inhibition of activated non-neuronal cells and modulation of pro-inflammatory cytokines. Neuropharmacology 2020;168:107992. [DOI: 10.1016/j.neuropharm.2020.107992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Celik MÖ, Labuz D, Henning K, Busch-Dienstfertig M, Gaveriaux-Ruff C, Kieffer BL, Zimmer A, Machelska H. Leukocyte opioid receptors mediate analgesia via Ca(2+)-regulated release of opioid peptides. Brain Behav Immun 2016;57:227-42. [PMID: 27139929 DOI: 10.1016/j.bbi.2016.04.018] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 9.2] [Reference Citation Analysis]
13 Salaga M, Mokrowiecka A, Zielinska M, Malecka-Panas E, Kordek R, Kamysz E, Fichna J. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration. J Pharmacol Exp Ther 2017;363:92-103. [PMID: 28724693 DOI: 10.1124/jpet.117.242586] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
14 Yang Y, Ni Z, Dong S. Effects of Endokinin A/B and Endokinin C/D on the antinociception of Endomorphin-1 in mice. Peptides 2010;31:689-95. [DOI: 10.1016/j.peptides.2009.12.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
15 Machelska H, Celik MÖ. Opioid Receptors in Immune and Glial Cells-Implications for Pain Control. Front Immunol 2020;11:300. [PMID: 32194554 DOI: 10.3389/fimmu.2020.00300] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 28.0] [Reference Citation Analysis]
16 Sałaga M, Sobczak M, Fichna J. Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract. Drug Discovery Today 2013;18:708-15. [DOI: 10.1016/j.drudis.2013.03.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
17 Horváth G, Szoke É, Kemény Á, Bagoly T, Deli J, Szente L, Pál S, Sándor K, Szolcsányi J, Helyes Z. Lutein inhibits the function of the transient receptor potential A1 ion channel in different in vitro and in vivo models. J Mol Neurosci 2012;46:1-9. [PMID: 21541689 DOI: 10.1007/s12031-011-9525-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
18 Jessop DS, Fassold A, Wolff C, Hofbauer R, Chover-Gonzalez A, Richards LJ, Straub RH. Endomorphins in rheumatoid arthritis, osteoarthritis, and experimental arthritis. Ann N Y Acad Sci 2010;1193:117-22. [PMID: 20398016 DOI: 10.1111/j.1749-6632.2009.05294.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
19 Zhang T, Zhang N, Zhang R, Zhao W, Chen Y, Wang Z, Xu B, Zhang M, Shi X, Zhang Q, Guo Y, Xiao J, Chen D, Fang Q. Preemptive intrathecal administration of endomorphins relieves inflammatory pain in male mice via inhibition of p38 MAPK signaling and regulation of inflammatory cytokines. J Neuroinflammation 2018;15:320. [PMID: 30442166 DOI: 10.1186/s12974-018-1358-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
20 Machelska H. Dual Peripheral Actions of Immune Cells in Neuropathic Pain. Arch Immunol Ther Exp 2011;59:11-24. [DOI: 10.1007/s00005-010-0106-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
21 Hongbao M, Yan Y, Shen C. Gender-specific effects of calcitonin gene-related peptide and substance P on coronary blood flow in an experimental model. Angiology 2009;60:569-75. [PMID: 19017671 DOI: 10.1177/0003319708325450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
22 Jain A, Brönneke S, Kolbe L, Stäb F, Wenck H, Neufang G. TRP-channel-specific cutaneous eicosanoid release patterns. Pain 2011;152:2765-72. [PMID: 21962912 DOI: 10.1016/j.pain.2011.08.025] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
23 Queiroz-junior CM, Maltos KL, Pacheco DF, Silva TA, Albergaria JD, Pacheco CM. Endogenous opioids regulate alveolar bone loss in a periodontal disease model. Life Sciences 2013;93:471-7. [DOI: 10.1016/j.lfs.2013.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
24 Kaczyńska K, Zając D, Wojciechowski P, Kogut E, Szereda-Przestaszewska M. Neuropeptides and breathing in health and disease. Pulm Pharmacol Ther 2018;48:217-24. [PMID: 29223509 DOI: 10.1016/j.pupt.2017.12.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]